| Outgoing Relation(s) |
| cardiotoxic agent (CHEBI:50912) is a aetiopathogenetic role (CHEBI:52209) |
| Incoming Relation(s) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has role cardiotoxic agent (CHEBI:50912) |
| 4-[(2,4-dimethylphenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid (CHEBI:87104) has role cardiotoxic agent (CHEBI:50912) |
| acid red 26 (CHEBI:82369) has role cardiotoxic agent (CHEBI:50912) |
| doxorubicinol (CHEBI:133817) has role cardiotoxic agent (CHEBI:50912) |
| fluoroacetaldehyde (CHEBI:14272) has role cardiotoxic agent (CHEBI:50912) |
| hexafluoropropylene oxide trimer acid (CHEBI:230529) has role cardiotoxic agent (CHEBI:50912) |
| nogalamycin (CHEBI:44504) has role cardiotoxic agent (CHEBI:50912) |
| pavettamine (CHEBI:178009) has role cardiotoxic agent (CHEBI:50912) |
| pirarubicin (CHEBI:94770) has role cardiotoxic agent (CHEBI:50912) |
| T-2 toxin (CHEBI:9381) has role cardiotoxic agent (CHEBI:50912) |
| taxine B (CHEBI:134192) has role cardiotoxic agent (CHEBI:50912) |
| tilmicosin (CHEBI:195409) has role cardiotoxic agent (CHEBI:50912) |